CD8A and cancer: Drijvers et al. observed that when co-cultured with cancer cells (B16, MC38), CD8+T cells exhibited higher sensitivity to RSL3-induced ferroptosis, resulting in a weaker tumor killing effect due to the elevated levels of ferroptosis in CD8+T cells compared to cancer cells.